申请人:May & Baker Limited
公开号:US04146631A1
公开(公告)日:1979-03-27
Benzamide derivatives of the formula:- ##STR1## wherein R.sup.1 represents a fluorine, chlorine or bromine atom, or an alkyl, alkoxy, alkylthio, alkylsulphonyl, alkanoylamino, alkylamino or alkylsulphamoyl group, each such group containing from 1 to 6 carbon atoms, a dialkylsulphamoyl, dialkylamino or dialkylcarbamoyl group (wherein the two alkyl groups may be the same or different and each contains from 1 to 4 carbon atoms), an alkanoyl, alkoxycarbonyl, alkoxycarbonylamino or alkylcarbamoyl group containing from 2 to 6 carbon atoms, or a hydroxy, formyl, nitro, trifluoromethyl, aryl, benzyloxycarbonylamino, amino, sulphamoyl, cyano, tetrazol-5-yl, carboxy, carbamoyl or aroyl group, and n represents an integer 1, 2 or 3, are new compounds possessing pharmacological properties, in particular properties of value in the treatment of respiratory disorders manifested by the interaction of tissue-fixed antibodies with specific antigens.
苯甲酰胺衍生物的化学式为:- ##STR1## 其中R.sup.1代表氟、氯或溴原子,或烷基、烷氧基、烷硫基、烷磺酰基、烷酰胺基、烷基胺基或烷基磺酰胺基,每个这样的基团含有1至6个碳原子,双烷基磺酰胺基、双烷基胺基或双烷基氨基甲酰基(其中两个烷基可能相同或不同,每个含有1至4个碳原子),含有2至6个碳原子的烷酰基、烷氧羰基、烷氧羰胺基或烷基氨基甲酰基,或羟基、甲酰基、硝基、三氟甲基、芳基、苄氧羰胺基、氨基、磺酰胺基、氰基、四唑-5-基、羧基、氨基甲酰基或芳酰基,n代表整数1、2或3,是具有药理特性的新化合物,特别是在治疗由组织固定抗体与特定抗原相互作用所表现出的呼吸系统疾病的治疗中具有价值的特性。